Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 517 of 1,261

  1. US 10206921

    Methods and compositions for treating a subject for central nervous system (CNS) injury

    The Regents of the University of California · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  2. US 10206904

    Licofelone derivatives and methods of use

    The Board of Regents of the University of Oklahoma · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  3. US 10206903

    Methods of treating muscular dystrophy

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  4. US 10206886

    Lipid nanoparticles for wound healing

    PRAXIS BIOPHARMA RESEARCH INSTITUTE · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  5. US 10206379

    Non-human animals having a humanized signal-regulatory protein gene

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  6. CA 3072544

    SACCHAROMYCES BOULARDII POUR LE TRAITEMENT DES TROUBLES DE L'HUMEUR

    BIOCODEX [FR] · Granted Feb 14, 2019 · Expires Feb 9, 2039

    granted

  7. US 10202367

    Heterocyclic compounds and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  8. US 10202657

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  9. US 10201596

    Peptide conjugated particles for the treatment of allergy

    Northwestern University · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  10. US 10202449

    Cachexia treatment

    XBIOTECH INC. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  11. US 10201547

    Method of treatment of aggression

    Supernus Pharmaceuticals, Inc. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  12. US 10202397

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  13. US 10201516

    Targeting K-Ras-mediated signaling pathways and malignancy by prostratin

    The Regents of the University of California · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  14. US 10202339

    Therapeutic compounds and compositions

    Agios Pharmaceuticals, Inc. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  15. US 10201609

    Method for the production of a formulation of a hypericin salt

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  16. US 10202618

    Method of treating type I diabetes using an AAV vector encoding uracortin 2

    The Regents of the University of California · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  17. US 10202605

    Methods of identifying and treating poor-prognosis cancers

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  18. US 10202603

    Modulation of huntingtin expression

    Ionis Pharmaceuticals, Inc. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  19. US 10202602

    Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

    Sarepta Therapeutics, Inc. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  20. US 10201554

    Esters of 2-deoxy-monosacharides with anti proliferative activity

    The Board of Regents of the University of Texas System · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  21. US 10201597

    Codon-optimized lentiviral vector for stem cell reprogramming

    The Regents of the University of California · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  22. US 10201591

    TSLP induces neutrophil mediated killing of methicillin-resistant staphylococcus aureus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  23. US 10201543

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  24. US 10201499

    Nanoparticle formulation

    United Kingdom Research and Innovation · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.